Evoq Remedies informs about revised annual report

07 Feb 2024 Evaluate
Pursuant to Regulation 34 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Evoq Remedies has informed that it submitting the Revised Annual Report for Financial Year 2021-22 due to discrepancy related to Related Parties Transactions in the Audit report. They were already submitted Annual Report for the Financial Year 2021-22, for the rectification the discrepancy they are submitting this revised Annual Report. There is no change in Annual Report other than Addition in Annexure in Directors report i.e. Annexure 3 and Disclosure of Related Parties transactions. 

The above information is a part of company’s filings submitted to BSE.

EVOQ Remedies Share Price

9.28 -0.47 (-4.82%)
14-Jun-2024 16:01 View Price Chart
Peers
Company Name CMP
Redington 216.95
Adani Enterprises 3263.50
Amrapali Industries 15.35
Rashi Peripheral 341.75
Compuage Infocom 3.71
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.